hexetidine: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
hexetidine: clinical details
Prescribing considerations
- Confirm that symptoms are suitable for local self-care; persistent or atypical lesions require assessment.
- The selected product is not recommended for children under 12 years.
- Ensure the patient can rinse or gargle safely without swallowing.
- It contains ethanol and azorubine, which may cause allergic reactions.
Contraindications and cautions
- Hypersensitivity to hexetidine or any excipient.
Monitoring
- Clinical response and persistence or recurrence of symptoms.
- Local irritation, altered taste, discolouration, ulceration or hypersensitivity.
- Assess a mouth ulcer lasting longer than three weeks or a sore throat that fails to improve.
Clinical pharmacology
Hexetidine is a locally acting broad-spectrum oral antimicrobial. Human absorption studies after topical use are unavailable; systemic exposure is predicted to be negligible, while retention on oral tissues and plaque has been demonstrated.
Formulation and product differences
- The selected product is a clear red mouthwash containing ethanol, azorubine, levomenthol and eucalyptus oil.
- It is essentially sodium-free and intended for undiluted oromucosal use.
- Protect from light, store below 30°C and use within six months after opening.
hexetidine interactions
No interactions with other medicines are known for the selected product. Tell a pharmacist or prescriber about other oral treatments if irritation occurs or you are unsure how to combine them.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.